Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World.
Hirschfeld CB, Shaw LJ, Williams MC, Lahey R, Villines TC, Dorbala S, Choi AD, Shah NR, Bluemke DA, Berman DS, Blankstein R, Ferencik M, Narula J, Winchester D, Malkovskiy E, Goebel B, Randazzo MJ, Lopez-Mattei J, Parwani P, Vitola JV, Cerci RJ, Better N, Raggi P, Lu B, Sergienko V, Sinitsyn V, Kudo T, Nørgaard BL, Maurovich-Horvat P, Cohen YA, Pascual TNB, Pynda Y, Dondi M, Paez D, Einstein AJ; INCAPS-COVID Investigators Group.
Hirschfeld CB, et al.
JACC Cardiovasc Imaging. 2021 Sep;14(9):1787-1799. doi: 10.1016/j.jcmg.2021.03.007. Epub 2021 Jun 16.
JACC Cardiovasc Imaging. 2021.
PMID: 34147434
Free PMC article.
We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. ...Significantly more U.S …
We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U. …